Double-blind comparison of ibuprofen and phenylbutazone in a short-term treatment of rheumatoid arthritis.
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001799:Blood Sedimentation; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007962:Leukocytes / Q000187:drug effects; D009088:Mucoproteins / Q000097:blood; D010653:Phenylbutazone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011422:Propionates / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014527:Uric Acid / Q000097:blood
D000893:Anti-Inflammatory Agents; D001593:Benzyl Compounds; D006454:Hemoglobins; D009088:Mucoproteins; D011422:Propionates; D014527:Uric Acid; D010653:Phenylbutazone